| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.18B | 63.79B | 59.25B | 59.21B | 55.23B | 48.12B |
| Gross Profit | 40.54B | 42.65B | 39.31B | 37.67B | 35.15B | 29.67B |
| EBITDA | 8.88B | 10.56B | 8.63B | 9.63B | 6.59B | 6.12B |
| Net Income | 4.41B | 5.11B | 4.20B | 4.68B | 3.17B | 2.07B |
Balance Sheet | ||||||
| Total Assets | 45.75B | 47.29B | 42.88B | 43.62B | 36.34B | 31.57B |
| Cash, Cash Equivalents and Short-Term Investments | 22.51B | 23.89B | 18.92B | 20.64B | 17.92B | 17.70B |
| Total Debt | 14.75B | 8.13B | 11.27B | 12.68B | 9.76B | 5.78B |
| Total Liabilities | 24.89B | 20.15B | 21.54B | 23.64B | 20.58B | 15.39B |
| Stockholders Equity | 16.30B | 21.48B | 17.09B | 16.18B | 12.95B | 12.37B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.60B | 5.50B | 3.55B | 950.00M | 3.78B |
| Operating Cash Flow | 0.00 | 10.05B | 5.67B | 4.45B | 1.46B | 4.67B |
| Investing Cash Flow | 0.00 | -2.99B | -1.45B | -1.15B | -1.29B | -1.00B |
| Financing Cash Flow | 0.00 | -2.25B | -2.92B | -882.00M | -358.00M | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.62B | 10.54 | ― | 2.22% | 25.61% | 39.61% | |
65 Neutral | ¥57.94B | 13.19 | 30.38% | 2.74% | 7.66% | 21.79% | |
65 Neutral | ¥944.93B | 17.87 | 49.14% | 2.82% | 6.33% | -2.52% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥47.68B | 20.81 | 14.53% | 0.21% | 22.16% | 18.65% | |
56 Neutral | ¥34.54B | 39.85 | ― | 0.82% | 48.10% | ― | |
41 Neutral | ¥1.68T | -12.21 | -21.14% | ― | 9.54% | -8.83% |